# No Prognostic or Molecular Disparity Between Synchronous and Metachronous Metastases in Differentiated Thyroid Cancer: Insight From Middle Eastern Cohort

> **NCT07115810** · — · COMPLETED · sponsor: **King Faisal Specialist Hospital & Research Center** · enrollment: 178 (actual)

## Conditions studied

- Differentiated Thyroid Cancer

## Interventions

- **OTHER:** No additional drugs(control Group)

## Key facts

- **NCT ID:** NCT07115810
- **Lead sponsor:** King Faisal Specialist Hospital & Research Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1988-01-01
- **Primary completion:** 2018-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 178 (ACTUAL)
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07115810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07115810, "No Prognostic or Molecular Disparity Between Synchronous and Metachronous Metastases in Differentiated Thyroid Cancer: Insight From Middle Eastern Cohort". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT07115810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*